Virginia House Bill 2200
Session 2023
Anti-cancer drugs; analyzing current reimbursement, etc., for medical practices that administer.
Became Law
Signed by Governor on Mar 26, 2023
Origin Chamber
House
Type
Bill
Bill Number
2200
State
Virginia
Session
2023
Motion Text
VOTE: Adoption (92-Y 0-N)
info
Roll call vote details are unavailable for VOTE: Adoption (92-Y 0-N)
House Roll Call Votes
info
Recorded roll call vote details are unavailable for VOTE: Adoption (92-Y 0-N)
Summary
Unavailable
Prefiled and ordered printed; offered 01/11/23 23103233D
January 11, 2023
Committee substitute printed 23107067D-S1
February 16, 2023
HB2200ER
March 7, 2023
Sort by most recent
03/26/2023
Office of the Governor
Acts of Assembly Chapter text (CHAP0582)
03/26/2023
Office of the Governor
Approved by Governor-Chapter 582 (effective 7/1/23)
03/13/2023
Office of the Governor
Governor's Action Deadline 11:59 p.m., March 27, 2023
03/13/2023
House
Enrolled Bill communicated to Governor on March 13, 2023
03/08/2023
Senate
Signed by President
03/08/2023
House
Signed by Speaker
03/07/2023
House
Bill text as passed House and Senate (HB2200ER)
03/07/2023
House
Enrolled
02/22/2023
House
VOTE: Adoption (92-Y 0-N)
02/22/2023
House
Senate substitute agreed to by House 23107067D-S1 (92-Y 0-N)
02/21/2023
Senate
Passed Senate with substitute (40-Y 0-N)
02/21/2023
Senate
Engrossed by Senate - committee substitute HB2200S1
02/21/2023
Senate
Committee substitute agreed to 23107067D-S1
02/21/2023
Senate
Reading of substitute waived
02/21/2023
Senate
Read third time
02/20/2023
Senate
Constitutional reading dispensed (40-Y 0-N)
02/16/2023
Senate
Committee substitute printed 23107067D-S1
02/16/2023
Senate
Senate committee, floor amendments and substitutes offered
02/16/2023
Senate
Reported from Finance and Appropriations with substitute (16-Y 0-N)
02/08/2023
Senate
Referred to Committee on Finance and Appropriations
02/08/2023
Senate
Constitutional reading dispensed
02/07/2023
House
VOTE: Passage (63-Y 35-N)
02/07/2023
House
Read third time and passed House (63-Y 35-N)
02/06/2023
House
Read second time and engrossed
02/03/2023
House
Read first time
02/01/2023
House
Reported from Finance (14-Y 8-N)
01/30/2023
House
Subcommittee recommends reporting (6-Y 0-N)
01/26/2023
House
Assigned Finance sub: Subcommittee #3
01/25/2023
House
Impact statement from TAX (HB2200)
01/18/2023
House
Impact statement from DHCD/CLG (HB2200)
01/11/2023
House
Referred to Committee on Finance
01/11/2023
House
Prefiled and ordered printed; offered 01/11/23 23103233D
Sources
Open States
Record Created
Jan 12, 2023 8:02:53 AM
Record Updated
Apr 1, 2023 9:04:49 AM